IL250818D0 - Methods and compositions for enhancing immune responses - Google Patents

Methods and compositions for enhancing immune responses

Info

Publication number
IL250818D0
IL250818D0 IL250818A IL25081817A IL250818D0 IL 250818 D0 IL250818 D0 IL 250818D0 IL 250818 A IL250818 A IL 250818A IL 25081817 A IL25081817 A IL 25081817A IL 250818 D0 IL250818 D0 IL 250818D0
Authority
IL
Israel
Prior art keywords
compositions
methods
immune responses
enhancing immune
enhancing
Prior art date
Application number
IL250818A
Other languages
Hebrew (he)
Original Assignee
Bavarian Nordic As
Us Health
Janssen Vaccines And Prevention B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201462045522P priority Critical
Priority to US201562116021P priority
Priority to US201562159823P priority
Priority to US201562189109P priority
Priority to PCT/US2015/048388 priority patent/WO2016036971A1/en
Application filed by Bavarian Nordic As, Us Health, Janssen Vaccines And Prevention B V filed Critical Bavarian Nordic As
Publication of IL250818D0 publication Critical patent/IL250818D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5256Virus expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
    • C12N2760/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
    • C12N2760/14011Filoviridae
    • C12N2760/14111Ebolavirus, e.g. Zaire ebolavirus
    • C12N2760/14134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
    • C12N2760/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
    • C12N2760/14011Filoviridae
    • C12N2760/14111Ebolavirus, e.g. Zaire ebolavirus
    • C12N2760/14171Demonstrated in vivo effect
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
    • C12N2760/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
    • C12N2760/14011Filoviridae
    • C12N2760/14211Marburgvirus, e.g. lake Victoria marburgvirus
    • C12N2760/14234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
IL250818A 2014-09-03 2017-02-27 Methods and compositions for enhancing immune responses IL250818D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US201462045522P true 2014-09-03 2014-09-03
US201562116021P true 2015-02-13 2015-02-13
US201562159823P true 2015-05-11 2015-05-11
US201562189109P true 2015-07-06 2015-07-06
PCT/US2015/048388 WO2016036971A1 (en) 2014-09-03 2015-09-03 Methods and compositions for enhancing immune responses

Publications (1)

Publication Number Publication Date
IL250818D0 true IL250818D0 (en) 2017-04-30

Family

ID=54207690

Family Applications (1)

Application Number Title Priority Date Filing Date
IL250818A IL250818D0 (en) 2014-09-03 2017-02-27 Methods and compositions for enhancing immune responses

Country Status (13)

Country Link
US (1) US20170340721A1 (en)
EP (1) EP3188754A1 (en)
JP (2) JP2017527564A (en)
KR (2) KR20190062617A (en)
CN (1) CN107106673A (en)
AP (1) AP201709822A0 (en)
AU (1) AU2015311868B2 (en)
CA (1) CA2960096A1 (en)
EA (1) EA201790507A1 (en)
IL (1) IL250818D0 (en)
MX (1) MX2017002890A (en)
SG (1) SG11201701745TA (en)
WO (1) WO2016036971A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3484507A1 (en) * 2016-07-15 2019-05-22 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against a marburg virus infection
WO2018011198A1 (en) * 2016-07-15 2018-01-18 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against a marburg virus infection
WO2018185732A1 (en) 2017-04-06 2018-10-11 Janssen Vaccines & Prevention B.V. Mva-bn and ad26.zebov or ad26.filo prime-boost regimen
WO2019023566A1 (en) * 2017-07-28 2019-01-31 Janssen Vaccines & Prevention B.V. Methods and compositions for heterologous reprna immunizations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150202272A1 (en) * 2012-09-04 2015-07-23 Bavarian Nordic A/S Methods and compositions for enhancing vaccine immune responses

Also Published As

Publication number Publication date
AP201709822A0 (en) 2017-03-31
EA201790507A1 (en) 2017-07-31
SG11201701745TA (en) 2017-04-27
US20170340721A1 (en) 2017-11-30
CA2960096A1 (en) 2016-03-10
KR20170072195A (en) 2017-06-26
AU2015311868B2 (en) 2018-11-22
MX2017002890A (en) 2017-11-13
JP2017527564A (en) 2017-09-21
CN107106673A (en) 2017-08-29
EP3188754A1 (en) 2017-07-12
WO2016036971A1 (en) 2016-03-10
KR20190062617A (en) 2019-06-05
JP2019123734A (en) 2019-07-25
AU2015311868A1 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
GB201414331D0 (en) Device and method
EP3152319A4 (en) Methods and compositions for nuclease design
IL249188D0 (en) Anti-her2 glycoantibodies and uses thereof
IL248143D0 (en) Methods and compositions for immunomodulation
GB201406151D0 (en) Method
IL250872D0 (en) Methods and compositions for attenuating anti-viral transfer vector immune responses
IL246762D0 (en) Mutagenesis methods
TWI623158B (en) Connector set and connector
TWI540138B (en) Organoaminosilanes and methods for making same
EP3096782A4 (en) Compositions and methods for modulating and redirecting immune responses
GB201403096D0 (en) Sample preparation method
IL249011D0 (en) Methods and compositions relating to exosomes
IL251248D0 (en) Anti-interleukin-33 antibodies and uses thereof
IL252854D0 (en) Immune modulation
ZA201701244B (en) Carrier-antibody compositions and methods of making and using the same
IL247413A (en) Methods and compositions for isolating exosomes
GB201406155D0 (en) Method
GB201409558D0 (en) Method
TWI598767B (en) Method to unclok device and thereof device
TWI587770B (en) Interposer assembly and method
TWI600730B (en) Polyoxometalate and heteropolyoxometalate compositions and methods for their use
IL252216D0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
IL259576D0 (en) Compositions and methods for immunooncology
GB201418159D0 (en) Method
GB201418469D0 (en) Method